Herbal medicine-induced toxic epidermal necrolysis in a 48-year old Filipino woman with invasive cervical cancer: a case report
Abstract
Toxic epidermal necrolysis (TEN) is a rare and severe dermatological emergency characterized by extensive necrosis and detachment of the epidermis, leading to significant mucous membrane erosions and severe systemic symptoms. While specific classes of conventional pharmaceuticals are identified as the primary cause of TEN, recent reports have implicated herbal medications as triggers. This case highlights a 48-year-old Filipino woman with invasive cervical cancer who developed TEN following the use of an herbal medication containing 23 botanical extracts. Despite immediate discontinuation of the herbal medication, the patient experienced rapid progression of vesicles and bullae to widespread epidermal detachment involving 90% of the body surface area. Histopathological examination confirmed the diagnosis of TEN. The patient was treated with systemic corticosteroids and supportive care, leading to a full recovery within 14 days. This case underscores the need for enhanced awareness among healthcare providers regarding the potential severe adverse drug reactions associated with herbal medicines and the necessity for stringent regulatory measures to ensure their safety. Moreover, underreporting of adverse events by both patients and healthcare professionals is due to a significant lack of awareness about the potential safety issues linked to herbal use. Therefore, enhanced education and strengthened regulatory policies are imperative to safeguard public health as the global use of herbal remedies and their associated adverse effects continue to rise.
Copyright (c) 2024 Nadra Magtulis, Mary Jo Kristine Bunagan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- Copyright and licensing: Authors retain copyright and grant the journal the right of first publication. The work is published under a Creative Commons Attribution-NonCommercial 4.0 International License that allows non-commercial sharing and reuse with appropriate acknowledgement of the authorship and initial publication in this journal.
- Non-exclusive distribution: Authors may enter into separate, additional, non-commercial contractual arrangements for the non-exclusive distribution of the published version of their work (e.g., posting in an institutional repository or inclusion in a book), with an acknowledgement of its initial publication in this journal.
- Editorial and publication rights: Authors grant the journal permission to rewrite, edit, modify, store and/or publish the submission, including abstracts, supplementary materials, and any necessary errata, in any medium or format, and in publicly available publications or databases.
- Originality and rights assurance: Authors warrant that the submission is original, that they hold the rights to the work, and that it does not infringe upon or violate the copyright or other rights of any third party.